Cara Therapeutics

Cara Therapeutics, which will now be known as Tvardi Therapeutics (TVRD) after the two completed its merger, is leading the Prism MarketView Cannabis index

Share this article:

About the Author:

Cara Therapeutics

Joey Ramson

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup